|
|
Volumn 31, Issue 5, 2005, Pages 403-407
|
|
Docetaxel plus prednisone improves survival in men with advanced prostate cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANALGESIC AGENT;
ANTIEMETIC AGENT;
DEXAMETHASONE;
DOCETAXEL;
ESTRAMUSTINE;
MITOXANTRONE;
PREDNISONE;
PROSTATE SPECIFIC ANTIGEN;
ADVANCED CANCER;
AGED;
ALOPECIA;
ANEMIA;
ANOREXIA;
CANCER PAIN;
CANCER SURVIVAL;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG FATALITY;
DYSPNEA;
EPISTAXIS;
EVIDENCE BASED MEDICINE;
FATIGUE;
FEBRILE NEUTROPENIA;
FOLLOW UP;
HEART LEFT VENTRICLE EJECTION FRACTION;
HUMAN;
LACRIMAL GLAND DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
MYALGIA;
NAIL DISEASE;
NEUROPATHY;
NEUROTOXICITY;
NEUTROPENIA;
PERIPHERAL EDEMA;
PROSTATE CANCER;
RANDOMIZED CONTROLLED TRIAL;
SCORING SYSTEM;
SHORT SURVEY;
SIDE EFFECT;
STATISTICAL ANALYSIS;
STATISTICAL SIGNIFICANCE;
STOMATITIS;
TASTE DISORDER;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
|
|
EID: 26444546826
PISSN: 03057372
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ctrv.2005.05.003 Document Type: Note |
|
Times cited : (3)
|
|
References (5)
|
